Literature DB >> 30707415

The role of miRNAs as a predictor of multicentricity in breast cancer.

Huseyin Akbulut1, Yeliz Emine Ersoy2, Ender Coskunpinar3, Zuhal Gucin4, Seyma Yildiz5, Fatma Umit Malya6, Burcu Hasturk7, Mahmut Muslumanoglu8.   

Abstract

Expression profiles of miRNAs are shown to be different in various cancers to regulate expression of mRNA or to have a role in inhibition of translation, thus it shows the possible effect in progression, invasion and metastasis of breast cancer cells. The effect of breast conserving treatment in local recurrence and survival rates for the patients who have multicentric breast cancer is still controversial. In our study, we intended to evaluate the foresight of 84 miRNAs which are identified in breast cancer for having differentiated expressions. Thirty-one patients with unifocal and 26 patients with multicentric breast cancer were included in this study. These tissue samples of both malignant and normal breast tissues were kept in RNA later solution at - 80 °C. Eighty-four miRNAs were studied with miScript miRNA PCR Array Human Breast Cancer kit. Fold change, cut off value was accepted as four. In unifocal group, there were 13 upregulated and five downregulated miRNAs and in multicentric group, there were three upregulated and seven downregulated miRNAs. To reach better results for breast cancer diagnosis and treatment, it is important to enlighten tumor biology, and pay attention to target and individual therapy. Thus, miRNAs have potential role in identifying tumor characteristics in supporting diagnosis and resulting with better evaluated disease for better treatment results with individual strategies.

Entities:  

Keywords:  Breast cancer; Expression; MicroRNAs; Multicentric; Multifocal

Mesh:

Substances:

Year:  2019        PMID: 30707415     DOI: 10.1007/s11033-019-04629-6

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  31 in total

1.  Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1.

Authors:  T K H Chung; T S Lau; T H Cheung; S F Yim; K W K Lo; N S S Siu; L K Y Chan; M Y Yu; J Kwong; G Doran; L M Barroilhet; A S W Ng; R R Y Wong; V W Wang; S C Mok; D I Smith; R S Berkowitz; Y F Wong
Journal:  Int J Cancer       Date:  2011-06-02       Impact factor: 7.396

2.  MicroRNA-141 regulates Smad interacting protein 1 (SIP1) and inhibits migration and invasion of colorectal cancer cells.

Authors:  Minghua Hu; MicroGene Xia; Xiaobing Chen; Zihong Lin; Yajun Xu; Yuedong Ma; Lei Su
Journal:  Dig Dis Sci       Date:  2009-10-15       Impact factor: 3.199

3.  MicroRNA expression profiling of male breast cancer.

Authors:  Matteo Fassan; Raffaele Baffa; Juan P Palazzo; Joshua Lloyd; Marco Crosariol; Chang-Gong Liu; Stefano Volinia; Hannes Alder; Massimo Rugge; Carlo M Croce; Anne Rosenberg
Journal:  Breast Cancer Res       Date:  2009-08-10       Impact factor: 6.466

4.  Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model.

Authors:  Li Ma; Ferenc Reinhardt; Elizabeth Pan; Jürgen Soutschek; Balkrishen Bhat; Eric G Marcusson; Julie Teruya-Feldstein; George W Bell; Robert A Weinberg
Journal:  Nat Biotechnol       Date:  2010-03-28       Impact factor: 54.908

5.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.

Authors:  Li Ma; Julie Teruya-Feldstein; Robert A Weinberg
Journal:  Nature       Date:  2007-09-26       Impact factor: 49.962

6.  Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells.

Authors:  Irene K Guttilla; Bruce A White
Journal:  J Biol Chem       Date:  2009-07-01       Impact factor: 5.157

Review 7.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

8.  MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome.

Authors:  J Ryan; A Tivnan; J Fay; K Bryan; M Meehan; L Creevey; J Lynch; I M Bray; A O'Meara; L Tracey; A M Davidoff; R L Stallings
Journal:  Br J Cancer       Date:  2012-08-14       Impact factor: 7.640

9.  miRSystem: an integrated system for characterizing enriched functions and pathways of microRNA targets.

Authors:  Tzu-Pin Lu; Chien-Yueh Lee; Mong-Hsun Tsai; Yu-Chiao Chiu; Chuhsing Kate Hsiao; Liang-Chuan Lai; Eric Y Chuang
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

10.  miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC).

Authors:  N Kikkawa; T Hanazawa; L Fujimura; N Nohata; H Suzuki; H Chazono; D Sakurai; S Horiguchi; Y Okamoto; N Seki
Journal:  Br J Cancer       Date:  2010-08-10       Impact factor: 7.640

View more
  2 in total

1.  A novel miR-338-3p/SLC1A5 axis reprograms retinal pigment epithelium to increases its resistance to high glucose-induced cell ferroptosis.

Authors:  Jing Zhou; Caoyu Sun; Xu Dong; Hui Wang
Journal:  J Mol Histol       Date:  2022-03-23       Impact factor: 2.611

Review 2.  Key Factor Regulating Inflammatory Microenvironment, Metastasis, and Resistance in Breast Cancer: Interleukin-1 Signaling.

Authors:  Fengjie Liu; Lihong Li; Meng Lan; Tengteng Zou; Zhaodi Kong; Tiange Cai; Xiao Yu Wu; Yu Cai
Journal:  Mediators Inflamm       Date:  2021-09-23       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.